Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
Getty, Perplexity sign multi-year licensing deal to boost AI-powered search visuals Perplexity will display pictures from Getty Images across its AI search and discovery tools under a multi-year deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback